Trademark Overview
On Monday, December 18, 2023, a trademark application was filed for EXO BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the EXO BIOLOGICS trademark a serial number of 98320218. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, December 23, 2023. This trademark is owned by EXO Biologics SA. The EXO BIOLOGICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical products for the treatment of diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases; biopharmaceutical products for diagnosing, preventing and treating diseases; chemical preparations for medical, pharmaceutical or veterinary purposes, especially chemical preparations for diagnosing diseases and in particular neurodegenerative diseases and cancers; medical diagnostic products and clinical diagnostic products, namel...
Medical services; veterinary services; medical assistance; consultancy in the field of pharmacy, namely, to assist in the selection of individuals affected by diseases for the purpose of clinical trials and to offer targeted care solutions and personalized treatments; hospitals; pharmaceutical industry and pharmacist (preparing prescriptions) services, namely, geriatric and/or neurological services, in order to facilitate diagnoses and treatment; health care; telemedicine services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software
Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues and blood samples; biotechnological project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices...
